Ligand Pharmaceuticals (LGND) Says Glaxo (GSK) Submits Regulatory Apps for Promacta/Revolade
Go back to Ligand Pharmaceuticals (LGND) Says Glaxo (GSK) Submits Regulatory Apps for Promacta/Revolade| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.41 +0.45 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.96 | 52 Week High | $45.58 | |||
| Open | $51.35 | 52 Week Low | $37.82 | |||
| Day High | $52.57 | P/E | N/A | |||
| Day Low | $51.35 | EPS | $0.00 | |||
| Volume | 2,404,769 | |||||
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 286.29 -1.1 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $287.39 | 52 Week High | $139.79 | |||
| Open | $288.09 | 52 Week Low | $82.07 | |||
| Day High | $289.98 | P/E | 665.79 | |||
| Day Low | $285.21 | EPS | $0.43 | |||
| Volume | 152,535 | |||||
